Equity, diversity and inclusion (EDI) is a key element of excellence in research. D2R’s vision is inherently driven by principles of EDI. From its inception, D2R was designed to deliver genomic-based RNA therapies that not only advance scientific discovery but also address the specific needs of medically underserved groups, including those affected by infectious diseases, rare and neglected diseases, as well as common chronic conditions such as cancer, cardiovascular and cardiometabolic diseases, and members of equity-deserving groups (EDGs). Moreover, D2R is committed to supporting the recruitment and advancement of RNA researchers from EDGs.
Have a question or concern related to EDI?
mariloue.daudier [at] mcgill.ca (Get in touch with our Senior EDI Advisor!)
